Mice lacking the complex subset ofN-glycans due to inactivation of the Mgatl gene die at mid-gestation, making it difficult to identify specific biological functions for this class of cell surface carbohydrates. To circumvent this embryonic lethality and to uncover tissue-specific functions for complex N-glycans, WW6 embryonic stem cells with inactivated Mgatl alleles were tracked in chimeric embryos. The Mgatl gene encodes N-acetylglucosaminyltransferase I (GlcNAc-TI; EC 2.4.1.101), the transferase that initiates the synthesis of complex N-glycans. WW6 cells carry an inert .8-globin transgene that allows their identification in chimeras by DNA-DNA in situ hybridization. Independent MgatP -' and Mgatl +1-mutant WW6 isolates contributed like parent WW6 cells to the tissues of embryonic day (E) 10.5 to E16.5 chimeras. However, a cell type-specific difference was observed in lung. Homozygous null Mgatl -l WW6 cells did not contribute to the epithelial layer in more than 999o bronchi. This deficiency was corrected by transfection of a Mgatl transgene. Interestingly, heterozygous Mgatl+'-WW6 cells were also deficient in populating the layer of bronchial epithelium. Furthermore, examination of lung bud in E9.5
Glycan units attached to protein or lipid are arrayed at the surface of mammalian cells and contain sugar sequences that may function as recognition determinants (1) . However, it is not clear to what extent the enormous variation in glycan structures has biological relevance. Since the action of specific glycosyltransferases generates the observed variety, questions of glycan function can be addressed by inactivating genes that code for these enzymes (2) (3) (4) (5) (6) . Interestingly, glycosylationdefective cell mutants with a highly simplified spectrum of surface glycans grow normally in culture (7) (8) (9) (10) . Thus, Chinese hamster ovary (CHO) cells lacking N-acetylglucosaminyltransferase I (GlcNAc-TI; EC 2.4.1.101) and synthesizing only oligomannosyl carbohydrates (Man5_9GlcNAc2Asn) at Nglycan sites, suffer no apparent consequences (8, 9) . By stark contrast, mice lacking GlcNAc-TI die at mid-gestation (2, 3) . Therefore, the complex N-glycans whose synthesis is prohibited in Mgatl-l-mice are essential for development beyond embryonic day (E) 9.5-10.5.
There is no single tissue or cell type that appears to be responsible for the demise of Mgatl-l-embryos (2, 3, 11) .
Mutant embryos are underdeveloped and show cellular disorganization in many tissues (2, 3) . Thus, specific functions for N-glycans are not readily apparent from the mutant phenotype. Strategies for circumventing embryonic lethality so as to identify specific consequences of a null mutation include tracking of mutant embryonic stem (ES) cells in chimeras (12) (13) (14) (15) , characterizing the differentiation properties of mutant ES cells (16) or the properties of mutant mouse embryo fibroblasts (17) , and replacing endogenous genes with a "floxed" homologue that can be inactivated in a particular tissue (18) . The former approach involves minimal assumptions and tests the widest range of possible functions. In fact, WW6 ES cells were developed specifically for this purpose (19) . They can be tracked to all nucleated cell types in chimeras by virtue of their inert ,B-globin transgene which is detected by DNA-DNA in situ hybridization (19) . In this paper we show that Mgatl -l-null mutant WW6 cells do not contribute to the epithelial cell layer in >99% of bronchi in E10.5 to E16.5 chimeric embryos and that E9.5 Mgatl--embryos have no morphologically recognizable layer of bronchial epithelium, revealing a cell type specific function for complex N-glycans.
MATERIALS AND METHODS
Isolation and Characterization of Mutant WW6 Cells. Independent WW6 ES cell lines with two disrupted Mgatl alleles were selected from 107 WW6. 15 Mgatl+l-WW6 cells (2) using medium containing 1.5 mg/ml of G418. After 12 days, 66 surviving colonies were plated into single wells of a 48-well tray containing SNL-2 feeder layer cells (2) . After 4 days at 37°C, cells from each well were replated onto two 35-mm dishes containing a feeder layer and expanded for freezing and characterization. All cell lines were grown for two passages without feeder layer cells and in the presence of leukemia inhibitory factor before characterization. Extraction of DNA and RNA, Southern and Northern blot analyses, assay of GlcNAc-TI activity, and detection of complex N-glycans by staining with fluoresceinated Phaseolus vulgaris leukophytohemagglutinin (L-PHA) were performed as described (2) . Differentiation to cystic bodies induced by retinoic acid treatment of WW6 cells in culture and tumor formation in nude mice were also performed as described previously (19) .
Chimera Production and in Situ DNA-DNA Hybridization. WW6 ES cells and mutant derivatives were injected into 3.5 days postcoitum (dpc) C57BL/6J blastocysts as described (2) .
At E10.5-16.5, embryos were recovered and chimeras that possessed the j3-globin transgene in yolk sac DNA were fixed as described (19) . Sagittal sections (5-7 gm) were hybridized to a biotinylated 13-globin gene probe and counterstained with hematoxylin and eosin Y as described (19) (20) , and either 25 ,ug DNA from a BamHI-linearized Mgatl cDNA in the plasmid pCDM7 (21) or 25 ,ug DNA from a HindIII-linearized AH32S3A subclone that carries a 3.8-kb Sacl genomic DNA fragment of the mouse Mgatl gene in pGEM-7Zf(+) (2, 21) . Electroporation was performed as described (2) in 0.6 ml of phosphatebuffered saline and cells were grown overnight in nonselective medium. Medium containing 2 ,uM puromycin and 1000 units of leukemia inhibitory factor per ml was added on the next day and replaced every 1-2 days. After 12 days, surviving clones were picked, expanded, and analyzed by staining with L-PHAfluorescein isothiocyanate as described (2) to identify transfectants expressing complex N-glycans. Cells from three stable clones were injected into 3.5 dpc blastocysts, and embryos were collected at E16.5, sectioned, and subjected to DNA-DNA in situ hybridization with the f3-globin probe as described (19 subjected to in situ hybridization and bronchi scored for cells containing the ,B-globin transgene. The number of sections scored was 60-100 per E14.5 and E16.5 chimera, 40 per E12.5 chimera, and 30 per E10.5 chimera. The number of bronchi per section was approximately equal for each chimera at a particular developmental stage, and therefore total bronchi examined are presented for simplicity. A bronchus was considered positive if at least one cell of the epithelial layer contained a hybridization signal. The number of positive cells in each bronchus was 13% to 250% for Mgatl +/+, 1-15% for Mgatl +/-, and one or two per bronchus for Mgatl-/-chimeras. To rescue Mgatl-/-cells with a Magtl transgene, WW6.10 cells were transfected with a genomic DNA fragment (X4) containing the coding region for GlcNAc-T1 or with a Mgatl cDNA (E15) under the control of a cytomegalovirus promoter/enchancer. Three chimeras were obtained from the transfectant WW6.10A4, but the results are not grouped because they differed significantly, presumably due to variation in the overall degree of embryonic chimerism. *Transfected with a Mgatl transgene.
Mgatl +1-ES cells were also markedly under-represented in bronchial epithelium (Table 1) . However, each cell line contributed, in proportion to its degree of chimerism, to lung mesenchyme (Fig. 2) , and to thyroid and pancreas (data not shown), which share their origins with lung.
Rescue of Mgatl' 1 Mutant Phenotype in Chimeras by a Mgatl Transgene. To prove that the Mgatl gene product was solely responsible for the markedly reduced ability ofMgatl -'-WW6 cells to contribute to the layer of bronchial epithelium, rescue was attempted by transfection of a Mgatl cDNA (21) under the control of the human cytomegalovirus promoter/ enhancer, or a 3.8-kb SacI genomic DNA fragment that contains the Mgatl coding region (Fig. 1) and no exogenous promoter (2) . Cotransfection with a plasmid containing a puromycin-resistance gene (20) allowed selection of transfectants. Survivors were characterized for complex N-glycan synthesis by L-PHA staining. Those exhibiting stable expression of a Mgatl transgene were injected into 3.5 dpc blastocysts and tracked in E16.5 chimeric embryos by in situ hybridization.
In a chimera obtained from a Mgatl cDNA transfectant (WW6.10E15), all tissues were extensively populated by transfectant descendants, but there was no contribution to lung epithelium ( Table 1) , showing that rescue had not occurred with this construct. However, in three chimeras obtained from a genomic DNA transfectant (WW6.10.A4), bronchial epithelium was populated in accord with the overall degree of chimerism of the embryo (Table 1 and Fig. 2) . Thus, an active Mgatl transgene was sufficient to rescue the ability ofMgatl -,-cells to populate the bronchial epithelial cell layer. One of the chimeras obtained from WW6.10.A4 cells, exhibited essentially complete rescue of the Mgatl-l-phenotype (Table 1) .
Absence of a Defined Bronchial Epithelium in MgatB-'-Embryos. Mgatl -'-WW6 mutant cells were similarly deficient in contributing to bronchial epithelium at developmental stages earlier than E16.5, including E14.5, E12.5, and E10.5 (Table 1 ). The fact that the Mgatl-1-cell defect was evident as early in development as E10.5, predicted that Mgatl --embryos containing exclusively Mgatl --cells, might completely lack a bronchial epithelium cell layer. Examination of sagittal sections of embryos at E9.5 revealed the lung bud with main bronchus lined by differentiated epitlielial cells in both wild-type and Mgatl 'I+ embryos (Fig. 3) . By contrast, their Mgatl-1-littermates had only a space of the appropriate contour for a bronchus in the lung bud, but no morphologically distinct epithelial cell layer was discernible (Fig. 3) . Therefore, complex N-glycans are essential for either the formation, differentiation, or maintenance of the organized epithelial cell layer that lines the bronchus.
DISCUSSION
The strategy of tracking WW6 ES cells that possess one or two inactivated Mgatl alleles in chimeras has identified a cell autonomous function for complex N-glycans in the development of a morphologically recognizable bronchial epithelium. Homozygous null Mgatl -l-ES cells essentially fail to contribute to the epithelial layer lining bronchi ( Fig. 2 and Tablel). They are not present at the earliest stage examined, E10.5 chimeras ( Table 1) . As might be expected from these findings, the bronchus in E9.5 Mgatl-/-mutant embryos lacks a morphologically distinct epithelial cell layer (Fig. 3) . The vival, the experiments pin-point a cellular defect that would have been extremely difficult to identify in any other way. The general cellular disorganization in E9.5 Mgatl-l-embryos precluded drawing specific functional conclusions from the fact that the bronchus in these embryos has no recognizable epithelial layer (Fig. 3) . Thus, tracking of WW6 mutant ES cells was critical to uncovering a specific requirement for complex N-glycans in forming or maintaining bronchial epithelium and should be useful in characterizing other mutations in the mouse.
